Tarsus Pharmaceuticals
Irvine, California, United States · Biopharma, Biotechnology, Health Care
Tarsus Pharmaceuticals, Inc. is a company specializing in biological products. They have shown substantial growth and have strategic initiatives in place, including the recent appointment of Dr. Elizabeth Yeu as the new Chief Medical Officer.
Key facts
- Headquarters
- Irvine, California, United States
- Employees
- 370
- Industries
- Biopharma, Biotechnology, Health Care
- Status
- Public (TARS)
- Website
- tarsusrx.com
- Company page
Recent activity at Tarsus Pharmaceuticals
- : Tarsus Pharmaceuticals to acquire Alkeus Pharmaceuticals
- : Tarsus Pharmaceuticals secures $125.0 million in oversubscribed Private Placement Equity Financing, led by Barclays with participation from TCGX and Bain Capital. The funds will support clinical development and corporate activities.
- : Tarsus Pharmaceuticals Appoints Neera Clase as Interim Chief Commercial Officer
- : Tarsus acquires iRenix Medical for IRX-101 development
- : Tarsus Pharmaceuticals Appoints Dr. Elizabeth Yeu, M.D., as Chief Medical Officer
Tarsus Pharmaceuticals funding history
| Date | Round | Amount |
|---|---|---|
| Aug 2026 | Post-IPO Equity | $125.0M |
Leadership
- Cindy, Sr. Director, Talent
- Neera Clase, Chief Commercial Officer
- Aziz, Chief Commercial Officer
- Elizabeth Yeu, Chief Medical Officer
Verified email and direct lines for Tarsus Pharmaceuticals’s decision-makers are on Fundz. See plans
Employee benefit plans
Tarsus Pharmaceuticals files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Tarsus Pharmaceuticals in the news
- Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care - GlobeNewswire (Sep 04, 2026)
- Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position - GlobeNewswire (Aug 06, 2026)
- Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing - GlobeNewswire (Aug 06, 2026)
- Tarsus Pharmaceuticals Announces Executive Leadership Transition as Company Advances Next Phase of Growth - GlobeNewswire (Jul 13, 2026)
- Tarsus to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 - GlobeNewswire (Aug 05, 2026)
- Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth - GlobeNewswire (Aug 06, 2026)
- Tarsus Advances Eye Care Leadership Strategy with Acquisition of iRenix Medical and Late-Stage Asset IRX-101 - GlobeNewswire (Jul 08, 2026)
- TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in - GlobeNewswire (Mar 23, 2026)
Companies similar to Tarsus Pharmaceuticals
- MacroGenics · Biopharma, Biotechnology, Health Care, Manufacturing, Pharmaceutical, Therapeutics
- TerSera · Biopharma, Biotechnology, Health Care, Manufacturing, Pharmaceutical, Therapeutics
- CASI Pharmaceuticals · Biopharma, Biotechnology, Health Care, Manufacturing, Pharmaceutical, Therapeutics
- Jubilant Therapeutics · Biopharma, Biotechnology, Health Care, Manufacturing, Pharmaceutical, Therapeutics
- AbbVie Inc. · Biopharma, Biotechnology, Health Care, Manufacturing, Pharmaceutical, Therapeutics
About Tarsus Pharmaceuticals: questions and answers
What does Tarsus Pharmaceuticals do?
Tarsus Pharmaceuticals, Inc. is a company specializing in biological products. They have shown substantial growth and have strategic initiatives in place, including the recent appointment of Dr. Elizabeth Yeu as the new Chief Medical Officer.
Where is Tarsus Pharmaceuticals headquartered?
Tarsus Pharmaceuticals is headquartered in Irvine, California, United States.
How many employees does Tarsus Pharmaceuticals have?
Tarsus Pharmaceuticals has about 370 employees.
Has Tarsus Pharmaceuticals raised funding?
Yes. Fundz has recorded 1 funding event for Tarsus Pharmaceuticals. The most recent, Post-IPO Equity of $125.0M, was in Aug 2026.
What is the latest news on Tarsus Pharmaceuticals?
On Aug 06, 2026, Tarsus Pharmaceuticals to acquire Alkeus Pharmaceuticals
Is Tarsus Pharmaceuticals a public company?
Yes. Tarsus Pharmaceuticals is publicly traded under the ticker TARS.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy